Live Price
Live Volume
Chart Volume 0
Volume 0
5 secRoivant Sciences Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.02(+0.05%)
| Open | $39.50 |
|---|---|
| Close | $39.52 |
| Low | $39.50 |
| Low Change | 0.00 (0.00%) |
| High | $39.62 |
| High Change | +0.12 (+0.30%) |
| Range | $0.12 |
| Volume | 1.756M |
| Dollar Volume | $69.40M |
Regular Trading Hours Yesterday
-1.46(-3.55%)
| Open | $40.96 |
|---|---|
| Close | $39.51 |
| Low | $39.22 |
| Low Change | -1.75 (-4.26%) |
| High | $41.14 |
| High Change | +0.18 (+0.44%) |
| Range | $1.93 |
| Volume | 5.983M |
| Dollar Volume | $236.35M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $41.15 |
|---|---|
| Close | $41.15 |
| Low | $41.14 |
| Low Change | -0.01 (-0.02%) |
| High | $41.15 |
| High Change | +0.00 (+0.00%) |
| Range | $0.01 |
| Volume | 713 |
| Dollar Volume | $29.34K |
Roivant Sciences News
1 week agoinvesting.comWhy is Roivant Sciences stock surging today?
1 week agobarrons.comRoivant Sciences Stock Soars as Lung Disease Drug Hits Goals
- 1 week agobarrons.com
S&P 500 Futures Decline in Premarket Trading; Roivant Sciences, Bloom Energy Lead
- 4 months agoinvesting.com
Why is Roivant Sciences stock surging today?
- 7 months agoinvesting.com
Roivant Sciences receives FDA priority review for dermatomyositis drug
- 7 months agoinvesting.com
Roivant Sciences stock soars after positive cutaneous sarcoidosis trial data
Roivant Sciences Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Roivant Sciences Moving Averages
| 5 Day Moving Average (SMA5) | $40.80 |
|---|---|
| 10 Day Moving Average (SMA10) | $38.36 |
| 20 Day Moving Average (SMA20) | $37.40 |
| 50 Day Moving Average (SMA50) | $35.99 |
| 100 Day Moving Average (SMA100) | $33.07 |
| 200 Day Moving Average (SMA200) | $29.10 |
Roivant Sciences Statistics
| Average Volume (30 Days) | 8.01M |
|---|---|
| P/E Ratio (Current) | -110.86 |
| EPS (Current) | -$0.37 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$821.06M |
| Cash Ratio | 4.40 |
| Current Ratio | 16.72 |
| Quick Ratio | 16.72 |
| Debt to Equity | 0.00 |
| Enterprise Value | $28.38B |
| EV to EBITDA | -20.81 |
| EV to Sales | 3768.09 |
| Price to Book | 7.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3933.84 |
| Return on Assets | -0.05% |
| Return on Equity | -0.06% |
Roivant Sciences Stock Splits
There have been no stock splits for Roivant Sciences (ROIV).
Roivant Sciences Dividends
There have been no dividends for Roivant Sciences (ROIV).